Comorbidity Assessment in Skin Cancer Patients: A Pilot Study Comparing Medical Interview with a Patient-Reported Questionnaire

Abstract

Background. Comorbidities are conditions that occur simultaneously but independently of another disorder. Among skin cancer patients, comorbidities are common and may influence management. Objective. We compared comorbidity assessment by traditional medical interview (MI) and by standardized patient-reported questionnaire based on the Adult Comorbidity Evaluation-27 (ACE-27). Methods. Between September 2011 and October 2013, skin cancer patients underwent prospective comorbidity assessment by a Mohs surgeon (MI) and a radiation oncologist (using a standardized patient-reported questionnaire based on the ACE-27, the PRACE-27). Comorbidities were identified and graded according to the ACE-27 and compared for agreement. Results. Forty-four patients were evaluated. MI and PRACE-27 identified comorbidities in 79.5% and 88.6% (p = 0.12) of patients, respectively. Among 27 comorbid ailments, the MI identified 9.9% as being present, while the PRACE-27 identified 12.5%. When there were discordant observations, PRACE-27 was more likely than MI to identify the comorbidity (OR = 5.4, 95% CI = 2.4–14.4, p < 0.001). Overall comorbidity scores were moderate or severe in 43.2% (MI) versus 59.1% (PRACE-27) (p = 0.016). Limitations. Small sample size from a single institution. Conclusion. Comorbidities are common in skin cancer patients, and a standardized questionnaire may better identify and grade them. More accurate comorbidity assessments may help guide skin cancer management.

Comparison of Physician-Documented Versus Patient-Reported Collection of Comorbidities Among Patients With Prostate Cancer Upon First Visit to the Urology Clinic

“…A similar study by Ye et al evaluating concordance between these two methods of comorbidity documentation reported agreement for the presence or absence of 20 medical conditions in over 90% of 881 prostate cancer patients 9 . Furthermore, a pilot study by Lee et al at MSKCC evaluated comorbidity capture in 44 skin cancer patients through either a medical interview or the patient-reported Adult Comorbidity Evaluation-27 questionnaire 10 . Within the two cohorts, medical interview captured comorbidities in 80% of patients, and the patient-reported survey captured comorbidities in 89% of patients.…”

A comprehensive geriatric assessment screening questionnaire (CGA-GOLD) for older people undergoing treatment for cancer

“…The number of assessors of validity and reliability was limited to two and though systematic methods were used, other assessors may potentially have assessed responses differently. Comorbidities depended on reliable self-report; however a recent study compared self-reported comorbidity using a patient questionnaire against traditional medical interview in patients with skin cancer and showed that the questionnaire identified comorbidity in more patients (88.6% versus 79.5%), and when there were discordant observations, was five times more likely to identify the comorbidity (Lee et al 2015). The majority of questionnaire responses were validated as reliable having been taken from evidence-based sources, but the memory question could be reinforced with another measure such as a clock drawing test (Shulman 2000), though that would have lengthened the completion time.…”

A minimal model of T cell avidity may identify subtherapeutic vaccine schedules

“…By estimating the parameter sensitivity of these candidate dosages, we can use a patient's history and clinical presentation to screen for suitable dosages. For example, a common co-morbidity for melanoma patients is diabetes (Lee et al, 2015). Diabetes is known to decrease phagocytosis by immune cells (Geerlings and Hoepelman, 1999), which in our model would correspond to a decreased rates of antigen uptake, k P and k Pi .…”